Orion Investment Co

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 2033920 ST. LOUIS, MO

Position in ARWR

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$3,920,944

+$842,440 QoQ

Shares Held

62,535

+34.9% QoQ

Ownership

0.044%

of shares outstanding

% of Portfolio

1.27%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Orion Investment Co holds $51,893,657 across 4 Biotechnology names. ARWR ranks #4 (7.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	30,837	$23,825,899
2	IONS	Ionis Pharmaceuticals Inc	225,015	$16,896,376
3	IOVA	Iovance Biotherapeutics, Inc.	2,065,652	$7,250,438
4	ARWR	Arrowhead Pharmaceuticals, Inc. This page	62,535	$3,920,944

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,920,944	62,535	+34.9%	Shares	Sole	2026-05-12
2025-12-31	$3,078,504	46,370	—	Shares	Sole	2026-02-11
No filing history on record for this holder in this stock.